Rare diseases
Investigational molecules
Locations
Back to Hungary14 clinical trials in Puspokladany, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
HungaryStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
HungaryEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
HungaryStudy on Long-Term Safety and Efficacy of Amlitelimab for Adults with Moderate to Severe Asthma
HungaryStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
HungaryStudy on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment
HungaryStudy of rocatinlimab compared to placebo to help adults with Moderate to Severe Asthma
HungaryStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)
HungaryStudy of Different Doses of Amlitelimab Given by Injection Under the Skin in Adults with Moderate to Severe Asthma
HungaryStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
HungaryStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
HungaryStudy on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
HungaryThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on moderate-to-severe asthma management, including studies of novel treatments like lunsekimig and dupilumab for preventing lung function decline and reducing exacerbations.
Multiple trials are evaluating innovative treatments for uncontrolled asthma cases.
Comprehensive research into Chronic Obstructive Pulmonary Disease treatments, examining both established and experimental therapies including triple therapy combinations and long-term management strategies.
Focus on improving quality of life for moderate to severe COPD patients.
Innovative investigations into refractory chronic cough treatments, with particular attention to unexplained cases through long-term efficacy and safety studies.
Specialized research aimed at addressing persistent cough conditions resistant to standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
